Fakultas

2025–2026

  1. Strengthening biobank infrastructure, Whole Genome Sequencing (WGS), and automated AST (Antimicrobial Susceptibility Testing) systems.
  2. Developing an integrated One Health-based AMR database.
  3. External grant submissions: ISPF 2025 (SHIELD project), WHO AMR program, RistekBRIN.
  4. Outputs: ≥2 Q1 publications, 1 AMR policy brief, 1 external grant proposal submitted.

2028–2029

  1. Community-based interventions: antibiotic education at primary health centers (Puskesmas) & pharmacies.
  2. Policy advocacy: contributing to the revision of PNPK (National Guidelines for Medical Care) & MoH PPRA (Antimicrobial Stewardship Program).
  3. Publication of research results & international conference presentations.
  4. Outputs: ≥2 policy briefs, 2 scientific publications, 1 popular science publication, 1 Intellectual Property Right (IPR).

2026–2027

  1. Implementation of cross-sectoral AMR surveillance in Jakarta & West Java.
  2. Translational studies.
  3. Benchmarking at international laboratories (UK/EU).
  4. Outputs: ≥3 Q1–Q2 publications, 1 Intellectual Property Right (IPR) for biosensors/primers, 2 external grant proposals granted.

2029–2030

  1. Consolidating research outcomes into the UI AMR Research & Training Center.
  2. Strengthening global research networks with Wellcome Trust, UKRI, and WHO.
  3. Formulating proposals for a national AMR research consortium.
  4. Outputs: ≥4 Q1–Q2 publications, 1 Intellectual Property Right (IPR), 1 national research consortium, 1 major international grant.

2027–2028

  1. Development of AMR epidemiological prediction models based on AI & machine learning.
  2. Multi-center research collaboration with hospitals and Veterinary Centers.
  3. Development of AMR teaching modules for students and fellowship programs.
  4. Outputs: ≥3 Q1–Q2 publications, 1 draft patent, 1 AMR teaching module.